Janssen PMP’s ECONEA™ receives positive vote for EU BPR approval for use as antifouling agent
Beerse, Belgium, 1 October 2014 – Janssen PMP, a division of Janssen Pharmaceutica NV, has announced that the EU Standing Committee on Biocidal Products has voted positively for the approval of ECONEA™ (tralopyril) under the EU Biocidal Products Regulation 528/2012 (EU BPR), for use as a new active substance for “Product Type 21”, which encompasses antifouling products.
“It has been a long journey but we are extremely pleased with the positive outcome of the review process for tralopyril under the EU BPR, a regulatory regime which is recognized for having some of the highest environmental and human health risk assessment standards in the world” said Dr Adrian Gray, Janssen PMP’s European Regulatory Manager. “Following this positive Standing Committee vote, publication of the EU Commission implementing regulation for the approval of tralopyril is expected within 2014, opening the door for applications for authorizations of antifouling paints containing ECONEA™ in the European Economic Area.”
Tony Kempen, Global Product Manager Microbial Control for Janssen PMP, added: “Since the shipping industry is a truly global industry, it has always been our strategic objective to support ECONEA™ under the various regulatory regimes worldwide. Following registrations in the USA, China, South Korea, Japan and a host of other countries in different parts of the world, this landmark EU BPR approval makes ECONEA™ the first and hitherto only copper alternative which has regulatory approvals in all major antifouling markets around the globe.”
ECONEA™ represents the latest generation of active substances for use in antifouling paints to prevent the settlement of unwanted aquatic organisms on ship hulls and other marine structures. Depending on the paint formulation, ECONEA™ is as effective as cuprous oxide at about one tenth the use concentration in the paint by weight. ECONEA™ is supported with extensive toxicological and environmental databases as well as approvals by regulatory authorities throughout the world. More information can be found at www.econea.com.
About Janssen PMP
Janssen PMP is a division of Janssen Pharmaceutica NV. Janssen is one of the most innovative pharmaceutical companies in the world with more than 40,000 employees. Janssen PMP has over 30 years of experience in the development and commercialization of innovative and sustainable products that are used to preserve and protect materials against biological degradation.
USE BIOCIDES SAFELY. ALWAYS READ THE LABEL AND PRODUCT INFORMATION BEFORE USE.
ECONEA™ MAY NOT BE REGISTERED FOR CERTAIN USES IN CERTAIN COUNTRIES. FOR MORE INFORMATION ON THE REGULATORY STATUS IN YOUR COUNTRY OF INTEREST, WE INVITE YOU TO CONTACT US.